Evidence map›Paper›PMID 35692905›Full record

ArticleEndoscopy international open2022

Endoscopic ultrasound as a reliable tool for assessment of pancreatic adenocarcinoma treatment: Example of in situ gene therapy.

Louis Buscail, Adrian Culetto, Fatima-Zhora Mokhrane, Bertrand Napoléon, Olivier Meyrignac, Baptiste Molinier, Marine Lebrin, Barbara Bournet, Emilie Bérard, Cindy Canivet

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Endoscopy international open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Louis BuscailDepartment of Gastroenterology and Pancreatology, CHU Toulouse-Rangueil (University Hospital Centre) and Toulouse University III, Toulouse, France.
Adrian CulettoDepartment of Gastroenterology and Pancreatology, CHU Toulouse-Rangueil (University Hospital Centre) and Toulouse University III, Toulouse, France.
Fatima-Zhora MokhraneDepartment of Radiology, CHU Toulouse-Rangueil and Toulouse University III, Toulouse, France.
Bertrand NapoléonDepartment of Gastroenterology, Jean Mermoz Hospital, Ramsay Générale de Santé (General Health), Lyon, France.
Olivier MeyrignacDepartment of Radiology, CHU Toulouse-Rangueil and Toulouse University III, Toulouse, France.
Baptiste MolinierDepartment of Radiology, CHU Toulouse-Rangueil and Toulouse University III, Toulouse, France.
Marine LebrinCentre for Clinical Investigation in Biotherapy, CHU Toulouse-Rangueil and INSERM U1436, Toulouse, France.
Barbara BournetDepartment of Gastroenterology and Pancreatology, CHU Toulouse-Rangueil (University Hospital Centre) and Toulouse University III, Toulouse, France.
Emilie BérardDepartment of Epidemiology, CHU of Toulouse & UMR 1027, CERPOP, INSERM, UPS, Toulouse University, Toulouse, France.
Cindy CanivetDepartment of Gastroenterology and Pancreatology, CHU Toulouse-Rangueil (University Hospital Centre) and Toulouse University III, Toulouse, France.
Hôpital Rangueil · FRInserm · FRGénérale de Santé · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35692905
PMCPMC9187414
OpenAlexW4281741506

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.